April 14 - 18, 2018
McCormick Place North/South
Chicago, Illinois, USA
Abstract submission deadline: Wednesday, January 24
Advance registration deadline: Monday, February 5
More than 160 clinical trials were submitted for presentation at the AACR Annual Meeting 2018, 40 of which were selected for oral presentation in minisymposia and plenary sessions.
Release of Clinical Trials Abstracts. The clinical trials and late-breaking abstracts are under embargo until 4:30 p.m. ET on Friday, April 13. The full text of all clinical trials abstracts will be released to the
online Proceedings and to the
Annual Meeting App at that time, with the exception of those abstracts that have been selected for inclusion in the AACR Press Program. Abstracts in the press program will be released at the date and time of presentation, either in the press conference or in the assigned session.
Live Streaming of Clinical Trials Plenary Sessions. The presentations in the Clinical Trials Plenary Sessions will be made available to the public in real time via live stream and will also be archived in the Annual Meeting webcast within 24 hours of each session. The presentation schedule is listed on the
live stream page. [Note: Participation in the live stream and the post-session webcast is left to the discretion of each speaker. As a result, some presentations may not be available for live streaming and webcasting, and some presentations may not include all slides.]
Presentation of Clinical Trials Abstracts. Clinical trials abstracts will be presented in the following sessions:
Opening Plenary Session. This session will feature the results of a phase III trial of pembrolizumab versus placebo after complete resection of high-risk stage III melanoma.
Top of page